Add BrightSurf on Google Email

Blood levels of ‘free range’ DNA may signal early detection of dementia and frailty

Researchers found that higher levels of cell-free DNA in the blood are associated with increased cognitive decline and worsening frailty over an eight-year period. The study suggests that a simple blood test could detect risk of Alzheimer's disease and other forms of cognitive decline, potentially leading to early interventions.

SourceJohns Hopkins Medicine·JournalJournal of Alzheimer’s Disease·DateOct 11, 2022

How the smell of food can enable “time travel”

Researchers at Lancaster University found that 3D printed flavor-based cues can stimulate rich sensory accounts and strong emotional connections in older adults, recalling memories from their youth. This technology has potential applications for dementia care, allowing individuals to relive cherished moments through the power of smell.

SourceLancaster University·JournalHuman-Computer Interaction·TypeExperimental study·DateOct 5, 2022

Neurodegenerative disease risk more than doubled among former Scottish international rugby union players

Research has found that former Scottish international rugby union players are at a significantly increased risk of developing neurodegenerative diseases, including dementia and motor neurone disease. The study's findings suggest that strategies to reduce head impact and traumatic brain injury in all sports are necessary.

SourceBMJ Group·JournalJournal of Neurology Neurosurgery & Psychiatry·TypeObservational study·DateOct 4, 2022

Risk of suicide after dementia diagnosis

A nationally representative study of 594,000 persons in England found an increased risk of suicide associated with dementia diagnosis before age 65. The study identified younger patients diagnosed within the 3-month post-diagnostic period as high-risk groups for suicidal thoughts and behaviors.

SourceJAMA Network·JournalJAMA Neurology·DateOct 3, 2022

National Institutes of Health Awards Cleveland Clinic $10.7 Million to expand national consortium studying Dementia with Lewy Bodies

The National Institutes of Health has awarded a $10.7 million grant to Cleveland Clinic to expand a national research consortium focused on improving diagnosis and treatments for Dementia with Lewy Bodies. The consortium, which includes multiple clinical sites, aims to identify biomarkers for disease and develop new therapies.

Race and ethnicity influence end-of-life care for Medicare patients with dementia

A Rutgers study found that racial and ethnic minorities with dementia receive more intensive end-of-life care. This disparity may be attributed to systemic racism, discrimination, or poor physician communication. The researchers suggest improving end-of-life care and outcomes for people with dementia through initiatives like advance ca...

SourceRutgers University·JournalJournal of the American Geriatrics Society·TypeData/statistical analysis·DateSep 29, 2022

Improving hospital stays and outcomes for older patients with dementia through AI

Researchers developed a machine learning model to quickly recognize predictive risk factors and their importance for undesirable hospitalization outcomes. The model achieved an accuracy of 95.6% and identified modifiable risk factors that can be mitigated through clinical interventions.

SourceHouston Methodist·JournalAlzheimer s & Dementia Translational Research & Clinical Interventions·TypeData/statistical analysis·DateSep 29, 2022

Two birds one stone strategy to treat both joint pain and cognitive impairment in rheumatoid arthritis

A study found that aberrant expression of MAO-B causes both peripheral and neuroinflammation in RA patients, leading to joint pain and cognitive impairment. Administering an MAO-B inhibitor called KDS2010 improved both joint inflammation and cognitive function in a RA animal model.

SourceInstitute for Basic Science·JournalExperimental & Molecular Medicine·TypeExperimental study·DateSep 28, 2022

Kidney disease measures are associated with structural brain damage across different domains of etiology

Reduced kidney function and increased urine albumin excretion are associated with brain volume reduction in regions typically affected by Alzheimer's disease and other dementia etiologies. Cognitive decline is common in patients with kidney disease, and this study provides new insights into the etiology and localization of brain damage.

SourceNational Kidney Foundation·JournalAmerican Journal of Kidney Diseases·DateSep 27, 2022

Study finds different comorbidities have different impacts on COVID outcomes

A new study found that certain pre-existing conditions have a more significant impact on COVID-19 outcomes than previously thought. Researchers developed a novel prediction model, PDeathDx, which outperformed conventional models and identified degenerative neurological diseases, dementia, and severe disabilities as major risk factors.

SourceOxford University Press USA·JournalBiology Methods and Protocols·TypeMeta-analysis·DateSep 27, 2022

Global consortium study, supported by the Alzheimer’s Association, aims to shed light on viruses’ impact on the brain

A global consortium study aims to understand the impact of SARS-CoV-2 on the brain, with researchers evaluating over 1,000 participants worldwide. The study, led by UT Health San Antonio, uses advanced brain imaging and neuropsychological tests to assess cognitive function and identify potential causes of long-term brain changes.

SourceUniversity of Texas Health Science Center at San Antonio·JournalAlzheimer s & Dementia Translational Research & Clinical Interventions·TypeObservational study·DateSep 22, 2022

EIP Pharma publishes translational data of preclinical and phase 2a results for Neflamapimod in dementia with Lewy bodies: Nature Communications

Neflamapimod, a p38α kinase inhibitor, demonstrates reversible neurodegeneration in animal models and improves clinical endpoints associated with cholinergic neuronal function in patients with dementia with Lewy bodies. The findings support the initiation of a confirmatory Phase 2b clinical trial for neflamapimod.

SourceLaVoieHealthScience·JournalNature Communications·TypeRandomized controlled/clinical trial·DateSep 21, 2022

Do sleep timing and duration affect dementia risk?

A cohort study of Chinese older adults found that sleeping for more than 8 hours increases dementia risk by 69% and going to bed before 9 PM doubles the risk. The study suggests monitoring cognitive function in those with prolonged sleep timing.

SourceWiley·JournalJournal of the American Geriatrics Society·DateSep 21, 2022

Nightmares in middle age linked to dementia risk

Research at the University of Birmingham suggests that people who experience frequent bad dreams in middle age are more likely to be diagnosed with dementia later in life. The study found that middle-aged individuals with weekly nightmares were four times more likely to experience cognitive decline over a decade.

SourceUniversity of Birmingham·JournalEClinicalMedicine·TypeData/statistical analysis·DateSep 21, 2022

As health problems stack up, so do serious financial woes, study shows

A new study from Michigan Medicine found that adults with more chronic health conditions are at higher risk of serious financial problems, including late payments, poor credit scores, and bankruptcy. The study analyzed nearly 3 million privately insured adults and found that those with seven or more chronic conditions had three to four...

SourceMichigan Medicine - University of Michigan·JournalJAMA Internal Medicine·TypeData/statistical analysis·DateSep 20, 2022

Mount Sinai researchers use artificial intelligence to uncover the cellular origins of Alzheimer’s disease and other cognitive disorders

The study used a weakly supervised deep learning algorithm to analyze human brain autopsy tissues and predict the presence or absence of cognitive impairment. The model identified a signal associated with decreasing myelin staining, which was linked to cognitive impairment in the white matter.

SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalActa Neuropathologica Communications·DateSep 20, 2022

Cognitive health may benefit from balanced meal timing

A recent study published in Life Metabolism found that maintaining balanced energy intake throughout the day may improve cognitive function. The study analyzed data from over 3,300 participants and discovered that those with unbalanced eating patterns, such as skipping breakfast, were at higher risk of cognitive decline.

SourceHigher Education Press·JournalLife Metabolism·TypeSurvey·DateSep 16, 2022

Aging | Extracellular microRNA and cognitive function in a prospective cohort of older men: The veterans affairs normative aging study

A new study has found associations between plasma miRNAs and cognitive function among cognitively normal men, including those with higher MMSE scores and slower rates of cognitive decline. These findings suggest that extracellular microRNAs may play a role in the early stages of cognitive decline.

SourceImpact Journals LLC·JournalAging-US·TypeObservational study·DateSep 15, 2022

Daily multivitamin may improve cognition and possibly protect against decline

A new study published in Alzheimer's & Dementia found that daily multivitamin-mineral supplementation resulted in statistically significant cognitive improvement in older adults. The researchers estimated that three years of multivitamin supplementation roughly translated to a 60% slowing of cognitive decline.

SourceAtrium Health Wake Forest Baptist·JournalAlzheimer s & Dementia·TypeRandomized controlled/clinical trial·DateSep 14, 2022

Study points to new approach to clearing toxic waste from brain

Researchers at Washington University School of Medicine have discovered a new pathway that could help prevent Alzheimer's dementia. Increasing the clearance of waste products in the brain by ramping up a genetic quirk known as readthrough may be effective for other neurodegenerative diseases, such as Parkinson's disease.

SourceWashU Medicine·JournalBrain·TypeExperimental study·DateAug 24, 2022

Revealing roles of dementia proteins in normal memory

A recent study has identified the tau protein's involvement in normal learning and memory processes in the healthy brain. The researchers used proximity labelling to map out all proteins that interact with tau and found that it interacts with enzymes controlling vesicles and cell surface receptors for neurotransmitters.

SourceFlinders University·JournalThe EMBO Journal·TypeObservational study·DateAug 22, 2022

Poor heart health predicts premature brain ageing

A study led by University College London found that poor heart health at age 36 predicts a higher brain age later in life, with men having older brains than women of the same age. The research used machine learning to estimate brain age from MRI scans and found an association between brain age and increased brain shrinkage over time.

SourceUniversity College London·JournalThe Lancet Healthy Longevity·TypeObservational study·DateAug 22, 2022

HKUMed & CityU researchers jointly discover non-invasive stimulation of the eye for depression and dementia

Researchers at HKUMed & CityU discover that transcorneal electrical stimulation can alleviate depression-like symptoms and improve cognitive function in animal models. The technique also induced the expression of genes involved in brain cell growth, offering a potential new treatment for Alzheimer's disease.

SourceThe University of Hong Kong·JournalBrain Stimulation·TypeExperimental study·DateAug 10, 2022

Johns Hopkins researchers find link between dementia and atrial cardiopathy

Researchers found a link between atrial cardiopathy and dementia in older adults, with those having the condition at a higher risk of developing dementia over time. The study suggests that subtle changes in the left atrium may be an independent risk factor for dementia, even after controlling for other vascular risk factors.

SourceJohns Hopkins Medicine·JournalJournal of the American Heart Association·DateAug 10, 2022